Eric S. Shinwell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric S. Shinwell has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
Isaac Blickstein
3 shared publicationsO Flidel-Rimon
Kaplan Medical Center, PO Box 1, Rehovot, Israel
3 shared publicationsO. Flidel-Rimon
Department of Neonatology, Kaplan Medical Center, Rehovot and Hebrew University, Jerusalem, Israel
3 shared publicationsOrna Flidel-Rimon
3 shared publicationsS. Eventov-Friedman
Department of Neonatology, Kaplan Medical Center, Rehovot and Hebrew University, Jerusalem, Israel
3 shared publicationsM. Shlomo
Department of Neonatology, Kaplan Medical Center, Rehovot and Hebrew University, Jerusalem, Israel
2 shared publications
Latest Publications
- 4 September 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (10) , 947-948
The ongoing challenge to prevent neonatal sepsis
- 4 September 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (10) , 947-948
The ongoing challenge to prevent neonatal sepsis
- 1 May 2013
- Published by S. Karger AG in Neonatology
- Vol. 103 (4) , 331-334
Optimization of Airway Medications in the Infant
Airway medications are frequently used in the care of the sick neonate. The most prominent airway medication, surfactant for respiratory distress syndrome, will be discussed elsewhere in this issue of Neonatology. Other indications for airway medications have included the prevention and treatment of bronchopulmonary dysplasia, pulmonary hypertension, persistent atelectasis, transient tachypnea of the newborn and upper airway edema. Indications such as the prevention of bronchopulmonary dysplasia are currently the focus of a large multicenter international trial. Other indications require further study.
- 1 May 2013
- Published by S. Karger AG in Neonatology
- Vol. 103 (4) , 331-334
Optimization of Airway Medications in the Infant
Airway medications are frequently used in the care of the sick neonate. The most prominent airway medication, surfactant for respiratory distress syndrome, will be discussed elsewhere in this issue of Neonatology. Other indications for airway medications have included the prevention and treatment of bronchopulmonary dysplasia, pulmonary hypertension, persistent atelectasis, transient tachypnea of the newborn and upper airway edema. Indications such as the prevention of bronchopulmonary dysplasia are currently the focus of a large multicenter international trial. Other indications require further study.
- Open Access
- 20 February 2013
- Published by Springer Nature in Israel Journal of Health Policy Research
- Vol. 2 (1) , 6
Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis
In Israel, an average of 37 children are born each year with sepsis and another four with meningitis as a result of Group B Streptococcal (GBS) disease. Israel currently only screens mothers with defined risk factors (around 15% of all pregnancies) in order to identify candidates for Intrapartum Antiobiotic Prophyhlaxis (IAP) of GBS. This paper presents a cost-utility analysis of implementing an alternative strategy, which would expand the current protocol to one aiming to screen all pregnant women at 35–37 weeks gestation based on taking a vaginal culture for GBS.
- 20 February 2013
- Published by Springer Nature in Israel Journal of Health Policy Research
- Vol. 2 (1) , 6
Open AccessShould Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis
In Israel, an average of 37 children are born each year with sepsis and another four with meningitis as a result of Group B Streptococcal (GBS) disease. Israel currently only screens mothers with defined risk factors (around 15% of all pregnancies) in order to identify candidates for Intrapartum Antiobiotic Prophyhlaxis (IAP) of GBS. This paper presents a cost-utility analysis of implementing an alternative strategy, which would expand the current protocol to one aiming to screen all pregnant women at 35–37 weeks gestation based on taking a vaginal culture for GBS.
- 16 August 2012
- Published by Wiley in Acta Paediatrica
- Vol. 101 (11) , 1183
Manual of Neonatal Respiratory Care
- 16 August 2012
- Published by Wiley in Acta Paediatrica
- Vol. 101 (11) , 1183
Manual of Neonatal Respiratory Care
- 22 July 2011
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 25 (6) , 654-655
Correlation between fetal heart rate reactivity and mortality and severe neurological morbidity in extremely low birth weight infants
Objective: To determine the correlation between specific fetal heart rate (FHR) abnormalities and the incidence of death, severe (grade 3–4) intraventricular hemorrhage (IVH) and periventricular echogenicity (PVE) in extremely low birth weight infants (ELBW) within the first 4 days after birth. Methods: The study included live-born ELBW infants ≤ 30 weeks’ gestation who were born in 2000–2007 at Kaplan Medical Center, Rehovot, Israel, and, who had FHR monitoring during the 24 h before delivery and cranial ultrasound during the first 4 days of life. FHR pattern was analyzed for the presence of baseline rate, reactivity, variability and decelerations. Results: 96 infants with mean birth weight 757 ± 150 g and mean gestational age 25.8 ± 1.5 weeks were included. By 4 days of life, 23/96 (24%) died, 17/96 (18%) developed severe IVH and 31/96 (32%) had PVE. Absence of reactivity was significantly associated with increase in both death (p = 0.02, OR 3.45, 95% CI: 1.22–9.47 and severe IVH (p = 0.029, OR 3.33, 95% CI: 1.25–10) but not with PVE. Other FHR parameters were not associated with adverse outcome. Conclusion: These results suggest that FHR reactivity may be of value in predicting short-term outcome in ELBW infants. This may be helpful in counseling parents with imminent extremely preterm birth.
- 22 July 2011
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 25 (6) , 654-655
Correlation between fetal heart rate reactivity and mortality and severe neurological morbidity in extremely low birth weight infants
Objective: To determine the correlation between specific fetal heart rate (FHR) abnormalities and the incidence of death, severe (grade 3–4) intraventricular hemorrhage (IVH) and periventricular echogenicity (PVE) in extremely low birth weight infants (ELBW) within the first 4 days after birth. Methods: The study included live-born ELBW infants ≤ 30 weeks’ gestation who were born in 2000–2007 at Kaplan Medical Center, Rehovot, Israel, and, who had FHR monitoring during the 24 h before delivery and cranial ultrasound during the first 4 days of life. FHR pattern was analyzed for the presence of baseline rate, reactivity, variability and decelerations. Results: 96 infants with mean birth weight 757 ± 150 g and mean gestational age 25.8 ± 1.5 weeks were included. By 4 days of life, 23/96 (24%) died, 17/96 (18%) developed severe IVH and 31/96 (32%) had PVE. Absence of reactivity was significantly associated with increase in both death (p = 0.02, OR 3.45, 95% CI: 1.22–9.47 and severe IVH (p = 0.029, OR 3.33, 95% CI: 1.25–10) but not with PVE. Other FHR parameters were not associated with adverse outcome. Conclusion: These results suggest that FHR reactivity may be of value in predicting short-term outcome in ELBW infants. This may be helpful in counseling parents with imminent extremely preterm birth.
- 1 May 2010
- Vol. 12 (5) , 259-61
The red reflex examination in neonates: an efficient tool for early diagnosis of congenital ocular diseases.
The American Academy of Pediatrics recently published recommendations for the red reflex assessment in the newborn period to detect and treat ocular disorders as early as possible, and to prevent lifelong visual impairment and even save lives. The test is technically simple to perform, non-invasive, requires minimal equipment and can detect a variety of ocular pathologies including cataracts and retinal abnormalities. No specific national guidelines exist on this issue. To document the implementation of red reflex examination in routine neonatal care and present the findings. Our clinical experience following inclusion of the red reflex test into the newborn physical examination in a single center was reviewed. In addition, an electronic mail questionnaire was sent to all neonatology departments in Israel regarding performance of the red reflex test. During 2007-2008, five infants were identified with congenital cataracts at days 2-6 of life prior to discharge from hospital. Surgery was performed in one infant at age 2 months and all infants underwent a thorough follow-up. The incidence of congenital cataract in our center was 1:2300. Less than half the neonatology departments have endorsed the AAP recommendation and perform the red reflex test routinely. Abnormal red reflex test after delivery enables a rapid ophthalmologic diagnosis, intervention and close followup. We recommend that red reflex screening be performed as part of the newborn physical examination; if abnormal, an urgent ophthalmologic referral should be made.
- 1 May 2010
- Vol. 12 (5) , 259-61
The red reflex examination in neonates: an efficient tool for early diagnosis of congenital ocular diseases.
The American Academy of Pediatrics recently published recommendations for the red reflex assessment in the newborn period to detect and treat ocular disorders as early as possible, and to prevent lifelong visual impairment and even save lives. The test is technically simple to perform, non-invasive, requires minimal equipment and can detect a variety of ocular pathologies including cataracts and retinal abnormalities. No specific national guidelines exist on this issue. To document the implementation of red reflex examination in routine neonatal care and present the findings. Our clinical experience following inclusion of the red reflex test into the newborn physical examination in a single center was reviewed. In addition, an electronic mail questionnaire was sent to all neonatology departments in Israel regarding performance of the red reflex test. During 2007-2008, five infants were identified with congenital cataracts at days 2-6 of life prior to discharge from hospital. Surgery was performed in one infant at age 2 months and all infants underwent a thorough follow-up. The incidence of congenital cataract in our center was 1:2300. Less than half the neonatology departments have endorsed the AAP recommendation and perform the red reflex test routinely. Abnormal red reflex test after delivery enables a rapid ophthalmologic diagnosis, intervention and close followup. We recommend that red reflex screening be performed as part of the newborn physical examination; if abnormal, an urgent ophthalmologic referral should be made.
- 1 June 2009
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 14 (3) , 164-170
Impact of perinatal corticosteroids on neuromotor development and outcome: Review of the literature and new meta-analysis
- 1 June 2009
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 14 (3) , 164-170
Impact of perinatal corticosteroids on neuromotor development and outcome: Review of the literature and new meta-analysis
- 6 March 2009
- Published by Wiley in Acta Paediatrica
- Vol. 98 (4) , 758-759
Microcephaly, lymphedema, chorioretinopathy and atrial septal defect: a case report and review of the literature
Background: The rare congenital combination of microcephaly, lymphedema and chorioretinopathy (MLCD) has been described. Recently, three cases with these clinical characteristics have been diagnosed as having, in addition, various congenital cardiac anomalies, which may be part of this genetic entity that presents with variable expression.Clinical observation: Here we present a new case of a one‐year‐old infant who was born with microcephaly and lymphedema and atrial septal defect (ASD) and developed chorioretinopathy at the age of 6 months. This infant had normal neurodevelopment at one year of age.Conclusion: We recommend that cardiac evaluation and long‐term ophthalmologic follow‐up should be part of the evaluation in each child born with microcephaly and lymphedema. Family counseling should include the fact that normal to near‐normal development may be possible, despite the presence of microcephaly.
- 6 March 2009
- Published by Wiley in Acta Paediatrica
- Vol. 98 (4) , 758-759
Microcephaly, lymphedema, chorioretinopathy and atrial septal defect: a case report and review of the literature
Background: The rare congenital combination of microcephaly, lymphedema and chorioretinopathy (MLCD) has been described. Recently, three cases with these clinical characteristics have been diagnosed as having, in addition, various congenital cardiac anomalies, which may be part of this genetic entity that presents with variable expression.Clinical observation: Here we present a new case of a one‐year‐old infant who was born with microcephaly and lymphedema and atrial septal defect (ASD) and developed chorioretinopathy at the age of 6 months. This infant had normal neurodevelopment at one year of age.Conclusion: We recommend that cardiac evaluation and long‐term ophthalmologic follow‐up should be part of the evaluation in each child born with microcephaly and lymphedema. Family counseling should include the fact that normal to near‐normal development may be possible, despite the presence of microcephaly.
- Open Access
- 2 October 2008
- Published by S. Karger AG in Neonatology
- Vol. 95 (1) , 6-14
Outcomes of Multiplets
Outcomes, both short and long term, differ between singletons and multiplets. Recently, a number of large, well-designed studies have clarified these differences, particularly in light of major changes in perinatal and neonatal care that have influenced changing outcomes. Accordingly, this article will review risks for singletons, twins and higher-order multiples as whole groups and also after correction for gestational age and other potential confounding variables that differ markedly between the groups. In addition, we will focus on the effects of certain factors such as antenatal steroid therapy and gender. Finally, we will detail the specific long-term risks for multiples in terms of growth and neurodevelopmental disabilities.
- 2 October 2008
- Published by S. Karger AG in Neonatology
- Vol. 95 (1) , 6-14
Open AccessOutcomes of Multiplets
Outcomes, both short and long term, differ between singletons and multiplets. Recently, a number of large, well-designed studies have clarified these differences, particularly in light of major changes in perinatal and neonatal care that have influenced changing outcomes. Accordingly, this article will review risks for singletons, twins and higher-order multiples as whole groups and also after correction for gestational age and other potential confounding variables that differ markedly between the groups. In addition, we will focus on the effects of certain factors such as antenatal steroid therapy and gender. Finally, we will detail the specific long-term risks for multiples in terms of growth and neurodevelopmental disabilities.